증시 대담<br /><br />It's time now for an in-depth look at the global markets this afternoon.<br />And for that, I'm joined on the line by Mr. Daniel Yoo, Global Strategist at Kiwoom Securities.<br />Mr. Yoo, thanks for coming on today.<br />You're welcome.<br />So, just ahead of this week's Fed meeting, U.S. stocks were up a little bit. The Dow a tenth of a percent, the S&P the same. What was driving the gains overnight and how about Asian markets?<br />Pfizer (+ 0.28%) announced it will acquire Array BioPharma (+ 56.94%), an anticancer manufacturer, for $ 11.4 billion. Cancer treatment companies such as Insight (+ 5.31%), Robens (+ 14.92%) and Turning Point Therapeutics (+ 6.84%) surged. As a result, bio-related ETFs such as XBI (+ 4.74%) and IBB (+ 2.96%) also rose. In particular, Moody's reported that Amgen (+ 1.31%), Biogen (+ 1.81%) and Gilli Adcience (+ 1.12%) showed high M & A ability resulting to related stock rise. <br />US S&P 0.09%, but Nasdaq rose 0.65%. <br />As for Asian markets, NiKkei down slightly by 0.2%, Shanghai and other Asian markets down slightly. Chinese equity market also showed some decline. <br />Korean market rose slightly 0.3% for Kospi and 0.2% for Kosdaq. <br />The U.S. measures against Huawei, the Chinese tech giant, have really dealt a blow. The company says the blacklisting is going to cost it some 30 billion dollars, this year and next. Its competitors and its business partners have started eyeing Korean companies. What's Huawei planning to do about all this?<br />Bloomberg and other foreigners are forecasting that Huawei smartphone shipments will decline by 40 to 60 million units this year. It means that 40-60% of overseas shipments will disappear considering Huawei's half shipments of exports (25.8 million units) last year.<br />If it realizes, Samsung Electronics will be able to widen the gap with Huawei. Strategy Analytics (SA), a market research firm, forecasts Samsung's 24.5% (344.4 million units), 13.7% (192.4 million units), Huawei 9.2% of the total. The share of Samsung and Huawei last year was 20.3% and 14.4% respectively. However, it is not uncommon for other Chinese manufacturers such as Xiaomi, Oppo, and Bibo to increase the market share.<br />The problem is the parts suppliers that get negatively affected by Huawei. Key components that Huawei receives from domestic companies are memory semiconductors such as DRAM and NAND flash, display panels such as organic light emitting diodes (OLED), and image sensors. In the case of Samsung, where Huawei is one of its top five customers, Huawei accounts for 2 ~ 2.5% of total sales, and SK Hynix, a semiconductor company, is estimated at 10 ~ 15% of total sales. The decline in sales of Huawei can also be attributed to a reduction in the supply portion of parts companies.<br /> With this trade war going on, China has been reducing its holdings of U.S. treasuries. Compared to last year, they're down around 70 billion dollars. Is this a card China can play when they meet the U.S. next week at the G20? Or what else might they want to do?<br />
